Axsome Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VANGUARD GROUP INC | 08/11/2025 | 3.95 M | $411.82 M | 1.76% | 7.98% |
BLACKROCK, INC. | 08/12/2025 | 3.83 M | $400.33 M | 8.81% | 7.76% |
BVF INC/IL | 08/14/2025 | 1.69 M | $176.44 M | 0.00% | 3.42% |
RTW INVESTMENTS, LP | 08/14/2025 | 1.52 M | $158.35 M | -48.10% | 3.07% |
MACQUARIE GROUP LTD | 08/14/2025 | 1.14 M | $118.77 M | 16.54% | 2.30% |
GEODE CAPITAL MANAGEMENT, LLC | 08/08/2025 | 989.45 K | $103.30 M | 5.84% | 2.00% |
FMR LLC | 08/14/2025 | 976.73 K | $101.96 M | -21.69% | 1.98% |
STATE STREET CORP | 08/14/2025 | 958.50 K | $100.06 M | 5.79% | 1.94% |
FAIRMOUNT FUNDS MANAGEMENT LLC | 08/14/2025 | 815.18 K | $85.10 M | 0.00% | 1.65% |
DEEP TRACK CAPITAL, LP | 08/14/2025 | 801.37 K | $83.66 M | 100.00% | 1.62% |
BANK OF AMERICA CORP /DE/ | 08/14/2025 | 753.43 K | $78.65 M | 41.12% | 1.52% |
EVENTIDE ASSET MANAGEMENT, LLC | 08/14/2025 | 725.67 K | $75.75 M | -2.57% | 1.47% |
WELLINGTON MANAGEMENT GROUP LLP | 08/14/2025 | 725.04 K | $75.69 M | 3.09% | 1.47% |
ALETHEA CAPITAL MANAGEMENT, LLC | 08/14/2025 | 667.37 K | $69.67 M | 0.00% | 1.35% |
PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2025 | 612.74 K | $63.97 M | 1,816.20% | 1.24% |
UBS GROUP AG | 08/14/2025 | 595.46 K | $62.16 M | 106.29% | 1.20% |
INVESCO LTD. | 08/13/2025 | 571.55 K | $59.66 M | -33.31% | 1.16% |
MAN GROUP PLC | 08/14/2025 | 525.07 K | $54.81 M | 2.31% | 1.06% |
PFM HEALTH SCIENCES, LP | 08/14/2025 | 483.11 K | $50.43 M | -13.20% | 0.98% |
NORGES BANK | 08/13/2025 | 468.33 K | $48.89 M | 100.00% | 0.95% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2025 | 447.00 K | $46.66 M | 831.25% | 0.90% |
ORBIMED ADVISORS LLC | 08/14/2025 | 427.90 K | $44.67 M | 10.65% | 0.87% |
PICTET ASSET MANAGEMENT HOLDING SA | 08/13/2025 | 411.85 K | $42.99 M | 23.60% | 0.83% |
NORTHERN TRUST CORP | 08/13/2025 | 409.39 K | $42.74 M | -0.38% | 0.83% |
QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2025 | 391.62 K | $40.88 M | 38.69% | 0.79% |
HOOD RIVER CAPITAL MANAGEMENT LLC | 08/14/2025 | 371.10 K | $38.74 M | 100.00% | 0.75% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2025 | 356.65 K | $37.23 M | 5.75% | 0.72% |
PRINCIPAL FINANCIAL GROUP INC | 08/08/2025 | 355.51 K | $37.11 M | 20.24% | 0.72% |
POINT72 ASSET MANAGEMENT, L.P. | 08/14/2025 | 350.97 K | $36.64 M | 178.12% | 0.71% |
WOODLINE PARTNERS LP | 08/14/2025 | 331.13 K | $34.57 M | 8.89% | 0.67% |
NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. | 07/25/2025 | 326.32 K | $34.06 M | 14.30% | 0.66% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2025 | 292.10 K | $30.49 M | 17.50% | 0.59% |
NUVEEN, LLC | 08/12/2025 | 282.97 K | $29.54 M | -31.51% | 0.57% |
FRANKLIN RESOURCES INC | 08/12/2025 | 278.51 K | $29.07 M | 22.95% | 0.56% |
LOOMIS SAYLES & CO L P | 08/13/2025 | 277.47 K | $28.96 M | -2.36% | 0.56% |
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2025 | 248.73 K | $25.97 M | -6.84% | 0.50% |
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 08/07/2025 | 224.72 K | $23.46 M | 27.72% | 0.45% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 08/14/2025 | 223.28 K | $23.31 M | 4.27% | 0.45% |
BANK OF NEW YORK MELLON CORP | 08/05/2025 | 203.63 K | $21.26 M | 55.42% | 0.41% |
PERCEPTIVE ADVISORS LLC | 08/14/2025 | 198.53 K | $20.72 M | -44.09% | 0.40% |
JPMORGAN CHASE & CO | 08/12/2025 | 187.73 K | $19.60 M | 50.44% | 0.38% |
BNP PARIBAS ARBITRAGE, SNC | 08/14/2025 | 186.44 K | $19.46 M | 2.08% | 0.38% |
METLIFE INVESTMENT MANAGEMENT, LLC | 08/13/2025 | 184.16 K | $19.22 M | 2.91% | 0.37% |
ASSENAGON ASSET MANAGEMENT S.A. | 07/11/2025 | 180.96 K | $18.89 M | -71.16% | 0.37% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2025 | 178.30 K | $18.61 M | -41.41% | 0.36% |
SQUAREPOINT OPS LLC | 08/27/2025 | 163.00 K | $17.02 M | 15.12% | 0.33% |
RAYMOND JAMES FINANCIAL INC | 08/14/2025 | 161.41 K | $16.85 M | 4.09% | 0.33% |
CUBIST SYSTEMATIC STRATEGIES, LLC | 08/14/2025 | 159.23 K | $16.62 M | -10.45% | 0.32% |
TRI LOCUM PARTNERS LP | 08/14/2025 | 157.86 K | $16.48 M | 55.93% | 0.32% |
FIRST TURN MANAGEMENT, LLC | 08/14/2025 | 144.40 K | $15.07 M | 22.19% | 0.29% |
Axsome Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 460 institutional investors and hedge funds held shares of Axsome Therapeutics, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 3.95 M
BlackRock, Inc.: 3.83 M
BVF INC/IL: 1.69 M
RTW INVESTMENTS, LP: 1.52 M
MACQUARIE GROUP LTD: 1.14 M
GEODE CAPITAL MANAGEMENT, LLC: 989,453
74.31% of Axsome Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 45.46 M shares in the last 24 months. This purchase volume represents approximately $5.39 B in transactions.